Trade Desk, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $TTD in the last 30 days.
See all $TTD insider activity →The Trade Desk plans to reprice up to 15.6 million employee stock options, citing concerns that a declining stock price could hurt staff retention. The move aims to make underwater options more attractive.
Trade Desk (TTD) and OptimizeRx integrated to connect EHR network to OpenPath, providing life sciences advertisers direct access to healthcare ad inventory. This expands Trade Desk's healthcare ad tools and aligns with its strategy of offering independent, data-rich ad solutions.
Argus lowered its price target for The Trade Desk (TTD) to $13.00, citing its self-service ad platform. The company helps advertisers buy digital ad inventory across various devices. TTD is in the communication services sector.
Over the past 7 days, AlphAI's AI scored 12 news stories mentioning TTD (Trade Desk, Inc.). Coverage has skewed bearish: 3 bullish, 3 neutral, and 6 bearish.
Recent TTD coverage spans market movers, corporate actions and technology.
Option repricing may boost employee morale and reduce turnover, potentially supporting share price stability.
The partnership expands The Trade Desk's healthcare ad inventory, potentially increasing demand for its DSP from pharma and health‑care brands.
Target cut suggests downside risk.
Potential incremental demand from pharma advertisers could boost TTD's revenue growth in the healthcare segment.
Cost cuts and a new financing vehicle could improve margins and provide liquidity, supporting a potential rebound from the 52‑week low.
AlphAI scores every news story that mentions TTD with an AI model for sentiment and relevance, and aggregates insider trades from Trade Desk, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
The Trade Desk plans to reprice up to 15.6 million employee stock options, citing concerns that a declining stock price could hurt staff retention. The move aims to make underwater options more attractive.
2 min readTrade Desk (TTD) and OptimizeRx integrated to connect EHR network to OpenPath, providing life sciences advertisers direct access to healthcare ad inventory. This expands Trade Desk's healthcare ad tools and aligns with its strategy of offering independent, data-rich ad solutions.
2 min readArgus lowered its price target for The Trade Desk (TTD) to $13.00, citing its self-service ad platform. The company helps advertisers buy digital ad inventory across various devices. TTD is in the communication services sector.
1 min readThe Trade Desk (TTD) is partnering with OptimizeRx (OPRX) to offer healthcare advertisers access to authenticated HCP inventory via its OpenPath platform, expected in Q4 2026. This integration complements TTD's recent healthcare data and measurement enhancements, potentially attracting more pharma advertisers. TTD's shares have fallen 71.9% year-over-year, trading at a forward P/E of 27.89X, above the industry average. The company has a Zacks Rank of #4 (Sell).
2 min readThe Trade Desk (TTD) stock hit a 52-week low of $12.81, down 71.87% over the past year. The company's market cap is now $6.09 billion. Analysts suggest potential undervaluation, while TTD announced a 15% workforce reduction, expecting $150 million in annual cost savings. Guggenheim and Evercore ISI raised price targets to $13.00 and $14.00, respectively.
2 min readThe Trade Desk (TTD) reported Q2 revenue of $715M (+3% YoY) and adjusted EBITDA of $241.3M, both below expectations. Management cited execution and macro headwinds. Analysts note intensifying AI-driven competition and lack of margin catalysts, suggesting potential structural challenges.
2 min readTrade Desk (TTD) shares fell 5.08% to $13.18 on Tuesday, with a market cap of $7.03B. Trading volume was below average. 24/7 Wall St. attributed the drop to index rebalancing, not company-specific news. TTD's next earnings report is due November 5, 2026.
2 min readThe Trade Desk Inc. (TTD) shares fell 5.01% amid concerns over slowing ad spend and valuation pressure. The company announced a 15% workforce reduction, which may result in $39–$51M in severance costs. TTD is also being removed from the S&P 500 and Bloomberg 500 Indexes, which could trigger passive fund selling. Despite solid financials, analysts remain neutral, with a consensus price target of $13.31.
2 min readThe Trade Desk, Inc. (TTD) was added to the S&P 1000 index and removed from the FTSE All-World Index. The company's stock has seen a 5-day change of 13.92 USD, a 1st Jan change of -2.38%, and a year-to-date change of -2.93%.
1 min readThe Trade Desk, Inc. (TTD) has been added to the S&P 600 Communication Services sector index. The company was previously part of the S&P 500 Value index. TTD's stock has seen a 5-day change of 13.92 USD, with a 1st Jan change of -2.38% and a year-to-date change of -63.33%.
1 min read
